FYMRALIN Trademark

Trademark Overview

On Friday, August 3, 2018, a trademark application was filed for FYMRALIN with the United States Patent and Trademark Office. The USPTO has given the FYMRALIN trademark a serial number of 88064191. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 1, 2022. This trademark is owned by TONIX Pharmaceuticals, Inc.. The FYMRALIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric-related diseases and disorders
fymralin

General Information

Serial Number88064191
Word MarkFYMRALIN
Filing DateFriday, August 3, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of sleep disorders, fibromyalgia, post-traumatic stress disorder, functional somatic disorder, disorders of the nervous system, disorders of the musculo-skeletal system, disorders of the endocrine system, disorders of the musculoskeletal system, neurological disorders, hormonal disorder, psychiatric-related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTONIX Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameTONIX Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Monday, August 1, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 1, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, December 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 30, 2021SOU EXTENSION 5 GRANTED
Tuesday, December 21, 2021SOU EXTENSION 5 FILED
Thursday, December 30, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 21, 2021TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 25, 2021SOU EXTENSION 4 GRANTED
Friday, June 25, 2021SOU EXTENSION 4 FILED
Friday, June 25, 2021TEAS EXTENSION RECEIVED
Thursday, December 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 22, 2020SOU EXTENSION 3 GRANTED
Tuesday, December 22, 2020SOU EXTENSION 3 FILED
Tuesday, December 22, 2020TEAS EXTENSION RECEIVED
Thursday, June 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 16, 2020SOU EXTENSION 2 GRANTED
Tuesday, June 16, 2020SOU EXTENSION 2 FILED
Tuesday, June 16, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019SOU EXTENSION 1 GRANTED
Monday, December 9, 2019SOU EXTENSION 1 FILED
Monday, December 9, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, May 5, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 8, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 21, 2018ASSIGNED TO EXAMINER
Thursday, August 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 7, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

fymralin disorders system disorder endocrine musculo skeletal musculoskeletal hormonal diseases related